Piperlongumine and some of its analogs inhibit selectively the human immunoproteasome over the constitutive proteasome.
Biochem Biophys Res Commun
; 496(3): 961-966, 2018 02 12.
Article
em En
| MEDLINE
| ID: mdl-29355526
The natural small molecule piperlongumine A is toxic selectively to cancer cells in vitro and in vivo. This toxicity has been correlated with cancer cell ROS, DNA damage and apoptotic cell death increases. We demonstrate here a new mechanistic property of piperlongumine: it inhibits selectively human immunoproteasome with no noticeable inhibition of human constitutive proteasome. This result suggests that immunoproteasome inhibition, a mechanism independent of ROS elevation, may also partly play a role in the anticancer effects observed with piperlongumine. Structure-activity relationships of piperlongumine analogs suggest that the lactam (piperidonic) ring of piperlongumine A may be replaced by the linear olefin -NHCO-CH2=CH2 to improve both in vitro inhibitory efficiency against immunoproteasome and cellular toxicity.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Imunoproteínas
/
Apoptose
/
Complexo de Endopeptidases do Proteassoma
/
Dioxolanos
Limite:
Humans
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article